Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.
2.

Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection.

Attallah AM, Toson el-SA, El-Waseef AM, Abo-Seif MA, Omran MM, Shiha GE.

Clin Chim Acta. 2006 Jul 15;369(1):66-72. Epub 2006 Mar 20.

PMID:
16545356
3.

Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.

Omran MM, Farid K, Emran TM, Attallah AA.

Arab J Gastroenterol. 2011 Jun;12(2):74-9. doi: 10.1016/j.ajg.2011.04.006. Epub 2011 May 17.

PMID:
21684477
4.

Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C.

Attallah AM, Toson EA, Shiha GE, Omran MM, Abdel-Aziz MM, El-Dosoky I.

J Immunoassay Immunochem. 2007;28(3):199-211.

PMID:
17613667
6.

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS.

Hepatology. 2003 Aug;38(2):518-26.

7.

Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.

Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, Lee PC, Tsay SH, Lee SD.

Hepatogastroenterology. 2002 Mar-Apr;49(44):478-81.

PMID:
11995477
8.

Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.

Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.

Int J Clin Pract. 2007 Mar;61(3):438-43.

PMID:
17313611
9.

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.

Hepatology. 2005 Jun;41(6):1376-82.

PMID:
15915455
10.

Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?

Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1459-65.

PMID:
19950810
11.

Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.

Gordon A, Bailey MJ, Gibson PR, Roberts SK.

J Gastroenterol Hepatol. 2005 Jun;20(6):825-32.

PMID:
15946128
12.

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis.

Fujii H, Enomoto M, Fukushima W, Ohfuji S, Mori M, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Ikura Y, Ueda M, Kawada N.

J Gastroenterol. 2009;44(6):608-14. doi: 10.1007/s00535-009-0046-6. Epub 2009 Apr 10.

PMID:
19360373
13.

Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.

Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M, Maltempo C, Felline C, Salerno F.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):797-804.

14.

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.

Sheth SG, Flamm SL, Gordon FD, Chopra S.

Am J Gastroenterol. 1998 Jan;93(1):44-8.

PMID:
9448172
15.

Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.

Khan DA, Fatima-Tuz-Zuhra, Khan FA, Mubarak A.

J Ayub Med Coll Abbottabad. 2008 Oct-Dec;20(4):122-6.

PMID:
19999223
16.

Predicting the liver histology in chronic hepatitis C: how good is the clinician?

Romagnuolo J, Jhangri GS, Jewell LD, Bain VG.

Am J Gastroenterol. 2001 Nov;96(11):3165-74.

PMID:
11721766
17.

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH.

J Gastroenterol Hepatol. 2000 Apr;15(4):386-90.

PMID:
10824882
18.

Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis.

Fortunato G, Castaldo G, Oriani G, Cerini R, Intrieri M, Molinaro E, Gentile I, Borgia G, Piazza M, Salvatore F, Sacchetti L.

Clin Chem. 2001 Sep;47(9):1696-700.

19.

Non-invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers.

Attallah AM, Abdallah SO, El Sayed AS, Omran MM, El-Bendary M, Farid K, Kadry M.

Hepatol Res. 2011 Nov;41(11):1075-84. doi: 10.1111/j.1872-034X.2011.00862.x.

PMID:
22035384
20.

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.

Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R.

Arch Intern Med. 2003 Jan 27;163(2):218-24.

PMID:
12546613

Supplemental Content

Support Center